Results highlighted several sociodemographic correlates to not meeting 5-a-day requirement among six Asian-American subgroups. Targeted health promotion measures for such at-risk groups should be implemented to improve dietary practices.

According to WHO, one of the most effective ways to protect people against COVID-19 is with the use of vaccines. As academic institutions prepare to fully re-open in the fall of 2021 and COVID-19 vaccines being readily accessible to all ages twelve and older in the U.S., college students are also getting ready to go back to normal campus operations for traditional in-person education. This raises the need to assess students’ attitudes toward the COVID-19 vaccines by identifying and addressing reasons for their hesitancy. One major threat to the impact of vaccination in preventing disease and deaths from COVID-19 is low utilization of vaccines by some groups. We conducted a pilot study and interviewed 55 undergraduate science students enrolled in summer school in 2021. The majority of the students were female, younger, Hispanic, or Latino, and at the junior or senior level. More than half of them have been vaccinated (62%) and indicated that it is important to attend classes while vaccinated (75%). While there were a variety of reasons for hesitancy ranging from lack of concern to lack of initiative, 17% of participants stated that religion played a role in their decision. Evidence-based recommendations strategies based on religion, ethical, and social implications are provided.

Counterfeit drugs are a global problem and a public health hazard. Nearly 10 percent of all medicines sold worldwide are fake, leading to an estimated 100,000 deaths each year, equating to an additional economic burden of close to $200 billion annually. Counterfeit medicines also thwart public health efforts to control infectious diseases like Covid-19 and Tuberculosis and lead to the worsening of other public health crises such as anti-microbial resistance (AMR). According to the CDC, more than 2.8 million antibiotic-resistant infections in the U.S each year, with more than 35,000 people dying, have been reported. Globalization and the internet's expansion have led to the rapid spreading of poor-quality medicines due to the high demand for cheap goods and lack of access - before adequate detection and intervention are possible. Moreover, selling counterfeit medicine is more profitable with lesser penalties, even in the U.S. As a clandestine market, there is no precise magnitude of how the counterfeit-medicine market flows. The WHO is alarmed by the lack of available data to demonstrate the extent and impact of fake/substandard medicines. Controlling counterfeit drugs' availability will not be easy; however, it has become necessary to protect public and global health. Through the lens of a case in Bangladesh that demonstrates how easy it is to sell and get away with selling fake medicines in developing countries - this paper discusses how counterfeit medicines negatively contribute significantly to human lives and sufferings in developing and developed countries. No single policy will be effective based on the different issues faced on multiple fronts due to fake/substandard medicines. However, a broad-based concerted effort across the various stakeholders to combat this counterfeit drug problem and secure the global supply chain is urgently needed.

No abstract

No abstract